14 niðurstöður
FIELD OF THE INVENTION
This invention relates to the use of .alpha.-linolenic acid metabolites for the treatment of cancer. More specifically, this invention relates to the use of stearidonic acid for treatment or prevention of cancer, particularly epithelial cell cancers such as, colon cancer,
FIELD OF INVENTION
The invention relates to iron-containing compositions and methods for the treatment of cancer.
PUBLISHED PATENT APPLICATIONS AND GENERAL LITERATURE
In previous Patent Applications of the inventor the role of essential fatty acids in cancer, and particularly of gamma-linolenic acid
FIELD OF INVENTION
The invention relates to iron-containing compositions and methods for the treatment of cancer.
PUBLISHED PATENT APPLICATIONS AND GENERAL LITERATURE
In previous Patent Applications of the inventor the role of essential fatty acids in cancer, and particularly of gamma-linolenic acid
BACKGROUND OF THE INVENTION
Gamma-linolenic acid (GLA) is an essential fatty acid in the omega-6 family that is found primarily in plant-based oils. GLA is synthesized from linoleic acid (LA) via the action of the enzyme delta-six desaturase (.DELTA.6-desaturase). The beneficial effects of GLA
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 or (.omega.-3) series
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series
The present invention relates to compositions containing select combinations of gamma linolenic acid (GLA), iodine, and preferably selenium, for improving breast health in women.
BACKGROUND OF THE INVENTION
Among the most common health issues affecting women today is that of breast health, most
FIELD OF THE INVENTION
The invention relates to the enhancement of the bodily action of interferons.
GENERAL BACKGROUND
The outline of production of 1-series and 2-series PGs in the body is believed to be as shown in the following diagram: ##STR1##
The broad outline of this pathway is well known,
FIELD OF THE INVENTION
This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein.
GENERAL BACKGROUND
Considerable interest has been shown in recent years in the use of prostaglandin
FIELD OF THE INVENTION
The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious
FIELD OF THE INVENTION
The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious
FIELD OF THE INVENTION
The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious